Promising New Agents for Colorectal Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-018-0543-z
Abstract: Opinion statementChoosing the optimal treatment approach for patients with metastatic colorectal cancer (mCRC) demands that oncologists assess both clinical and genomic variables and individualize care based upon the findings. Clinically, choices depend on assessing the… read more here.
Keywords: promising new; colorectal cancer; disease; new agents ... See more keywords
New drugs in early development for treating multiple myeloma: all that glitters is not gold
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2020.1772753
Abstract: ABSTRACT Introduction The last twenty years have introduced new therapeutic agents for multiple myeloma (MM); these include proteasome inhibitors (PIs), immunomodulatory drugs (IMDs) and monoclonal antibodies (mAbs). However, MM remains incurable, hence there is an… read more here.
Keywords: early development; drugs early; development treating; multiple myeloma ... See more keywords
Rebellious Tin Ore Processing with New Agents for Nonferrous and Noble Metal Recovery
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Mining Science"
DOI: 10.1134/s1062739119056209
Abstract: The occurrence form of sodium dibutyl dithiocarbamate on chalcopyrite is defined by IR spectroscopy. A stable compound of lead dibutyl dithiocarbamate forms on galenite. Fat acids of tall oil are adsorbed at the surface of… read more here.
Keywords: rebellious tin; tin ore; tin; ore processing ... See more keywords
Future Management Of Chronic Myeloid Leukemia: From Dose Optimization To New Agents.
Sign Up to like & getrecommendations! Published in 2022 at "Current cancer drug targets"
DOI: 10.2174/1568009622666220613144253
Abstract: BACKGROUND The outcome of chronic myeloid leukemia (CML) patients in chronic phase has changed after the introduction of tyrosine kinase inhibitors (TKIs). The life expectancy is actually similar to that of the general population. Although… read more here.
Keywords: myeloid leukemia; chronic myeloid; future management; new agents ... See more keywords